Journal
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
Volume 19, Issue 7, Pages 824-832Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/10837450.2013.836218
Keywords
Bioavailability; in vitro cytotoxicity; solid lipid nanoparticles; tamoxifen citrate
Categories
Ask authors/readers for more resources
The objective of this study was to evaluate the influence of solid lipid nanoparticles (SLN) loaded with the poorly water-soluble drug tamoxifen citrate (TC) on the in vitro antitumor activity and bioavailability of the drug. TC-loaded SLN were prepared by solvent injection method using glycerol monostearate (GMS) or stearic acid (SA) as lipid matrix. Poloxamer 188 or tween 80 were used as stabilizers. TC-loaded SLN (F3 and F4) prepared using GMS and stabilized by poloxamer 188 showed highest entrapment efficiency % (86.07 +/- 1.74 and 90.40 +/- 1.22%) and reasonable mean particle sizes (130.40 +/- 9.45 and 243.80 +/- 12.33 nm), respectively. The in vitro release of TC from F3 and F4 exhibited an initial burst effect followed by a sustained drug release. In vitro cytotoxicity of F3 against human breast cancer cell line MCF-7 showed comparable antitumor activity to free drug. Moreover, the results of bioavailability evaluation of TC-loaded SLN in rats compared to free TC indicated that 160.61% increase in the oral bioavailability of TC. The obtained results suggest that incorporation of the poorly water-soluble drug TC in SLN preserves the in vitro antitumor activity and significantly enhance oral bioavailability of TC in rats.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available